A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness

  1. Matthew G. Guenther1,
  2. William S. Lane2,
  3. Wolfgang Fischle3,
  4. Eric Verdin3,
  5. Mitchell A. Lazar1,5, and
  6. Ramin Shiekhattar4
  1. 1Division of Endocrinology, Diabetes, and Metabolism, Departments of Medicine and Genetics, and The Penn Diabetes Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 USA; 2Harvard Microchemistry Facility, Harvard University, Cambridge, Massachusetts 02138 USA; 3Gladstone Institute of Virology and Immunology, University of California, San Francisco, San Francisco, California 94141 USA; 4The Wistar Institute, Philadelphia, Pennsylvania 19104 USA

Abstract

The corepressor SMRT mediates repression by thyroid hormone receptor (TR) as well as other nuclear hormone receptors and transcription factors. Here we report the isolation of a novel SMRT-containing complex from HeLa cells. This complex contains transducin β-like protein 1 (TBL1), whose gene is mutated in human sensorineural deafness. It also contains HDAC3, a histone deacetylase not previously thought to interact with SMRT. TBL1 displays structural and functional similarities to Tup1 and Groucho corepressors, sharing their ability to interact with histone H3. In vivo, TBL1 is bridged to HDAC3 through SMRT and can potentiate repression by TR. Intriguingly, loss-of-function TRβ mutations cause deafness in mice and humans. These results define a new TR corepressor complex with a physical link to histone structure and a potential biological link to deafness.

Keywords

Footnotes

  • 5 Corresponding author.

  • E-MAIL lazar{at}mail.med.upenn.edu; FAX (215) 898-5408.

    • Received February 11, 2000.
    • Accepted March 21, 2000.
| Table of Contents

Life Science Alliance